Cas:525-03-1 9H-Fluoren-9-amine manufacturer & supplier

We serve Chemical Name:9H-Fluoren-9-amine CAS:525-03-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

9H-Fluoren-9-amine

Chemical Name:9H-Fluoren-9-amine
CAS.NO:525-03-1
Synonyms:9H-Fluoren-9-amine;9-Fluorenylamine;fluorene-9-ylamine;FLUOREN-9-AMINE;9-amino-9H-fluorene;9-Aminofluoren;9-aminofluorene;9H-fluoren-9-yl-amine;Fluoren-9-ylamine;MFCD00871339
Molecular Formula:C13H11N
Molecular Weight:181.233
HS Code:2921499090

Physical and Chemical Properties:
Melting point:64ºC
Boiling point:331.1±31.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.657
PSA:26.02000
Exact Mass:181.089142
LogP:2.70

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 9H-Fluoren-9-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00871339 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,fluorene-9-ylamine Use and application,9-Aminofluoren technical grade,usp/ep/jp grade.


Related News: Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. 9H-Fluoren-9-amine manufacturer Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity. 9H-Fluoren-9-amine supplier The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. 9H-Fluoren-9-amine vendor When they do design their phase 3, they’re going to need to be better about that part of the study design, and really focus on enrolling individuals that have the right biomarkers to be able to look at not only the safety and tolerability but also the efficacy on cognition and function,” Edelmayer said.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau. 9H-Fluoren-9-amine factory The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.